UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported)
October 15, 2007 (October 15, 2007)

GENE LOGIC INC.
(Exact name of registrant as specified in its charter) 

--------------------------------------------------------------------------------
      DELAWARE                       0-23317                    06-1411336
--------------------------------------------------------------------------------
(State of Incorporation)     (Commission File Number)         (IRS Employer
                                                          Identification Number)
--------------------------------------------------------------------------------

                            50 West Watkins Mill Road
                          Gaithersburg, Maryland 20878
                    (Address of principal executive offices)

                                 (301) 987-1700
              (Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act


(17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SECTION 9. FINANCIAL STATEMENTS AND EXHIBITS 

Item 9.01.                 Financial Statements and Exhibits.

(c)          Exhibits

          Exhibit Number          Description
-----------------------------    ----------------------------------------------

               99.1               Press Release  issued by Gene Logic Inc. dated
                                  October 15, 2007 with respect to the sale of
                                  Genomics Assets to Ocimum Biosolutions Ltd.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GENE LOGIC INC. 

Date: October 15, 2007              By:

                                         /s/ Philip L. Rohrer, Jr.
                                        ----------------------------------------
                                        Philip L. Rohrer, Jr.
                                        Chief Financial Officer

3

EXHIBIT INDEX 

Exhibit Number             Description
----------------------    -----------------------------------------------

          99.1             Press release issued by Gene Logic Inc. dated October
                           15, 2007 with respect to the sale of Genomics Assets
                           to Ocimum Biosolutions Ltd.

4
Gene Logic Inc. (MM) (NASDAQ:GLGC)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Gene Logic Inc. (MM) 차트를 더 보려면 여기를 클릭.
Gene Logic Inc. (MM) (NASDAQ:GLGC)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Gene Logic Inc. (MM) 차트를 더 보려면 여기를 클릭.